PIK3CA Mutations in Gallbladder Carcinoma
Author Information
Author(s): Deshpande Vikram, Nduaguba Afamefuna, Zimmerman Stephanie M, Kehoe Sarah M, MacConaill Laura E, Lauwers Gregory Y, Ferrone Cristina, Bardeesy Nabeel, Zhu Andrew X, Hezel Aram F
Primary Institution: Massachusetts General Hospital, Harvard Medical School
Hypothesis
To characterize mutations in established oncogenes and tumor suppressor genes in biliary tract cancers.
Conclusion
Activating mutations in PIK3CA are specifically found in gallbladder carcinoma, which has implications for diagnosis and targeted therapies.
Supporting Evidence
- Activating mutations in PIK3CA were identified in 4 out of 32 gallbladder carcinoma samples.
- KRAS mutations were found in intra-hepatic cholangiocarcinomas but not in gallbladder carcinomas.
- The study used a high-throughput mass-spectrometric platform for mutation profiling.
Takeaway
This study found that a specific mutation in a gene called PIK3CA is common in gallbladder cancer, which could help doctors treat this type of cancer better.
Methodology
Mass spectrometric genotyping was used to analyze mutations in 77 formalin-fixed paraffin-embedded biliary tract cancer samples.
Limitations
The study may have missed some mutations due to the quality of DNA extracted from samples.
Participant Demographics
The cohort included 33 gallbladder carcinoma samples with a mean age of 66 years, consisting of 25 females and 8 males.
Statistical Information
P-Value
0.013
Statistical Significance
p = 0.013
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website